Emily Atkins PHD

Dr. Emily R. Atkins, Ph.D. is a Senior Research Fellow at The George Institute for Global Health. She completed her Ph.D. at the University of Western Australia using linked administrative hospital morbidity, deaths, and pharmacy data to investigate the cost-effectiveness of cardiovascular medicines for the secondary prevention of atherothrombotic disease.

Dr. Atkins is focused on better use of proven medicines, particularly blood pressure lowering. Her current interest is cardiovascular medicines use in high- and low-resource settings, and equity in access to cardiovascular medicines. She is working on a number of studies investigating different methods to improve the efficacy and use of blood pressure-lowering therapy. Dr. Atkins has clinical trial experience, working as a research fellow on the QUARTET trial, funded by the National Health and Medical Research Council. She is analyzing nationwide data on blood pressure, seasonality, and treatment patterns for an estimated 2 million people from MedicineInsight. She received a National Heart Foundation Vanguard Grant to study Dose Administration Aids for delivering combination therapy.

Dr. Atkins is on the Executive Team and Scientific Advisory Committee of the Australian and New Zealand Alliance for Cardiovascular Trials, and a member of the Australian Clinical Trial Alliance reference group for innovative Trial Design and Conduct. She currently supervises three Ph.D. students with a fourth beginning in 2020, including three recipients of the prestigious Scientia Scholarship at UNSW Sydney.